Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

Two days after approving a jobs grant for the pharmaceutical giant Roche to build a plant in Wake County, the N.C. Economic ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

Swiss pharmaceutical and diagnostics giant Roche pledged on Monday to inject at least $700 million into the construction of a new plant in the United States.